Welcome to our dedicated page for Medical Care Technologies news (Ticker: MDCE), a resource for investors and traders seeking the latest updates and insights on Medical Care Technologies stock.
Medical Care Technologies Inc. develops and commercializes artificial intelligence applications across consumer software, imaging analysis, healthcare-oriented pre-screening and collectibles authentication. News about MDCE centers on its AI technology stack, including Snapshot Recipes, a mobile recipe application with AI-generated food and beverage content, and Real Game Used, a subsidiary developing a patent-pending AI authentication platform for sports memorabilia.
Company updates also cover AI imaging initiatives for dermatological analysis, wellness monitoring, product verification and automated quality control, as well as capital and asset-monetization activity through Infinite Auctions. Recurring announcements describe product redesigns, commercialization pathways, subsidiary activity, mobile-app user growth initiatives, and enterprise API or visual analytics use cases.
Medical Care Technologies (OTC Pink: MDCE) announced its Regulation A Tier 1 offering will formally conclude on December 6, 2025, ending the dilution period tied to that offering and stopping further share issuance under Reg A.
The company said proceeds from the offering, together with an intentionally lean cost structure, have positioned MDCE to focus on product launches, revenue expansion, and AI innovation throughout 2026. Planned initiatives include a debut consumer-facing nutrition intelligence and recipe generation mobile platform and continued growth of subsidiaries Infinite Auctions and Real Game Used.
Medical Care Technologies (OTC Pink: MDCE) announced on December 4, 2025 a strategic acceleration toward AI-driven health and wellness mobile applications.
The company says it will leverage two operating subsidiaries, Infinite Auctions (since 2016) and Real Game Used (since 2017), as stable revenue and brand pillars while shifting focus to build a catalog of AI apps for medical pre-screening, nutrition, wellness, and food intelligence. MDCE identified the first product as a food and recipe AI mobile app positioned in a multi-billion-dollar market and described this release as a foundation for broader consumer health AI offerings.
Medical Care Technologies (OTC Pink: MDCE) on December 3, 2025 described a lean AI operating model that relies on outsourcing and API extensions to reduce overhead and increase agility.
The company contrasted its approach with large AI firms that invest hundreds of millions in proprietary infrastructure, saying MDCE avoids heavy capital and remains flexible. MDCE noted it has a pending patent application but is not dependent on that approval to continue development or deliveries. Management emphasized the model supports faster pivots, lower fixed costs, and continued innovation while minimizing reliance on single intellectual property outcomes.
Medical Care Technologies (OTC PINK: MDCE) is expanding development of consumer-grade AI pre-health screening mobile apps to detect early warning signs of serious conditions and prompt timely medical follow-up.
The initiative builds on MDCE's prior work in early melanoma detection and broadens its AI models to assess dermatology (skin lesions), ocular health markers, and lifestyle and health-behavior risk trends. The tools are described as deep-learning models trained on medical datasets and designed to provide consumer-friendly preliminary screening insights via mobile devices.
Management emphasizes early detection and aims to make proactive screening technology widely accessible from smartphones.
Medical Care Technologies (OTC PINK: MDCE) announced on December 1, 2025 that its first consumer AI mobile application has entered Apple iOS TestFlight, described as the final testing phase before App Store release. The app targets a $13.4 billion global health and nutrition app market and represents MDCE's first major consumer product outside its medical roadmap.
The company plans a sequential rollout: complete iOS TestFlight, obtain App Store approval and launch iOS, begin Google Play testing, then pursue a global Android launch after Google approval. Management said the app showcases internal development and AI capabilities and that a leading marketing agency will be engaged at launch. MDCE will provide ongoing investor updates as testing and feature refinement continue.
Medical Care Technologies (OTC Pink: MDCE) announced it has begun a new infrastructure and early system testing phase to scale its AI-driven health analytics platform on November 25, 2025. The company said work targets both a Clinical AI Division (clinical validation track) and a Consumer AI Division (preventive health, emotional wellness, dietary and lifestyle tools).
Preparatory activities listed include architecture optimization, module compatibility testing, data ingestion stress tests, early safety and compliance assessments, and predictive model tuning. Management framed these steps as groundwork for continued development and testing.
Medical Care Technologies (OTC Pink: MDCE) reported that its subsidiaries have generated $848,987 year-to-date, including $478,218 in Q3, while the company was ranked #2 on InvestorsHub's Breakout Board on November 21, 2025.
Infinite Auctions contributed six-figure revenue from a Fall Flash Auction and a consignment agreement with Fanatics Collect. Real Game Used, an AI-assisted authentication unit, maintains an order log of more than 50 high-end evaluations. The company says it is advancing testing, feature development, and infrastructure for upcoming AI-driven mobile health and nutrition products, with additional milestones to be announced in coming weeks.
Medical Care Technologies (OTC Pink: MDCE) subsidiary Infinite Auctions will conclude its Fall Flash Auction on Saturday, November 22, 2025 at 9:00 PM EST on www.infiniteauctions.com. The online event features a curated lineup of rare game-worn and autographed memorabilia from athletes including Michael Jordan, LeBron James, and Tiger Woods. Several highlight items were authenticated by Real Game Used (RGU), a company subsidiary using AI-driven photo-matching and artifact authentication. Collectors can view, register, and bid now on the auction site.
Medical Care Technologies (OTC PINK:MDCE) announced that CEO Marshall Perkins purchased 50,000,000 shares of MDCE common stock on the open market at an average price of $0.0003 per share on November 19, 2025.
The purchase was made with personal funds, did not involve issuance of new company shares, and therefore did not constitute a corporate action. The company reported an unchanged outstanding share count of 3,316,305,988 common shares as of the release date.
Management said the purchase reflects alignment with shareholders and ongoing focus on transparent communications while the company pursues activities in health technology and digital wellness.
Tom Brady collectible (NASDAQ:MDCE) — A 2009 Topps Unique Tom Brady 1-of-1 game-worn NFL Shield Patch Autograph card, graded PSA 6 (EX-MT), is live in Fanatics Collect Premier Auction with no reserve and the auction ends November 20, 2025. The unsigned 1-of-1 sold for $78,000 on September 25, 2025, and a comparable Brady 1/1 patch autograph sold for $485,000 at Sotheby’s in 2024, providing market context for expectations that this lot may breach six figures.
The card was consigned to Fanatics Collect via a consignment agreement with Infinite Auctions.